Navigation Links
Harvard Medical School releases 2010 Annual Report on Prostate Diseases,

Experts weigh the benefits of PSA screening in groundbreaking publication

Boston (Vocus) March 11, 2010 -- Harvard Medical School today released its first ever Annual Report on Prostate Diseases, which covers the basics in the diagnosis and treatment of prostate cancer, benign prostatic hyperplasia (BPH), erectile dysfunction, prostatitis, and related issues, along with recent scientific and medical advances. A group of talented prostate disease specialists contributed to the publication.

Also included in this groundbreaking report is an explanation of the growing body of evidence indicating that the benefits of PSA screening may not outweigh the potential harm of unnecessary treatment, a concept that counters current medical practice.

Given the ongoing debate, Dr. Marc Garnick, editor in chief of the 2010 Annual Report on Prostate Diseases, invited three experts to participate in a roundtable discussion on screening. The trio shared their thoughts on PSA screening and explained its pros and cons in easy-to-understand terms. An edited version of their conversation appears in the publication to help readers make an informed decision about PSA screening for themselves.

Here is an excerpt from the report:
“PSA screening has always been somewhat controversial. That’s because PSA tests often alert doctors to the presence of cancer, but there is no precise way to determine, definitively, whether the cancers detected would have ever caused symptoms or harm during a man’s lifetime,” the report explains. “One study estimated overdetection to rise with age, from 27% at age 55 to 56% by age 75. Despite this, to be on the safe side, most men with elevated PSA levels will opt for treatment, frequently suffering side effects such as incontinence and impotence.”

In the past few years, more and more men who undergo PSA screening and later learn that they have cancer have opted to pursue active surveillance. This strategy involves frequent monitoring of the disease through PSA tests and biopsies—and postponing treatment until the cancer shows signs of increasing its activity. In short, these men choose to live with prostate cancer until it advances, sometimes avoiding potentially life-altering side effects for several years.
Among other things, readers will learn about the following topics not only from world-renowned experts, but also from patients living with prostate disease:

  • options in radiation therapy for prostate cancer
  • medications for an enlarged prostate (benign prostatic hyperplasia)
  • treating erectile dysfunction and incontinence after prostate surgery
  • easing the pain of prostatitis
  • complementary therapies for prostate diseases.

Dr. Garnick, a distinguished expert in medical oncology and urologic cancer, serves as the publication’s editor in chief. He is a clinical professor of medicine at Harvard Medical School, and he maintains an active clinical practice at the Harvard-affiliated Beth Israel Deaconess Medical Center. Dr. Garnick also authored A Patient’s Guide to Prostate Cancer.

The 136-page 2010 Annual Report on Prostate Diseases is currently available for $59 from Harvard Health Publications (, the publishing division of Harvard Medical School. To order a copy, call 877–649–9457 (toll-free) or visit

Members of the media: Contact Raquel Schott at Raquel_Schott(at)hms(dot)harvard(dot)edu for a complimentary copy of the report or to receive our press releases directly.

Harvard Health Publications
Contact: Raquel Schott


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest
2. Partners Harvard Medical International Set to Play Key Role as Saudi Arabia Pursues Ambitious Health Care Transformation
3. Solutions for Sleep Problems: Harvard's Improving Sleep Special Health Report and New Sleep Apnea Video
4. Early Factors Predict Later-Life Stroke Risk, from the Harvard Health Letter
5. Albina du Boisrouvray Congratulates New Director of FXB Center for Health and Human Rights at Harvard University
6. World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins
7. Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University
8. The Top Health Stories Of 2009, From The Harvard Health Letter
9. Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
10. Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study
11. Throw a Yellow Flag on Football-related Head Injuries, Warns the Harvard Mental Health Letter
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... way that they are handling security in light of the recent terrorist attacks in ... an attempt to stop an attack from reaching U.S. soil. Especially around special events ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was ... inventor from Hillside, N.J. "Many people catch diseases simply from sitting on such ... always be protected from germs." , He developed the patent-pending QUDRATECS to eliminate ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 27, 2015 , ... The moment you stop improving is ... fulfilling the needs of advisers and clients but going above and beyond to ... customer service. However, there's always room for improvement, which is why the entire ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Dr. ... Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., ... observed that both STEMI and Sepsis conditions present in similar ways and require time-critical ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: